We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Therapeutic Cancer Vaccine Demonstrates Good Safety and Efficacy in Preclinical Study

News   Nov 24, 2020 | Original story from The Ohio State University Comprehensive Cancer Center

 
Therapeutic Cancer Vaccine Demonstrates Good Safety and Efficacy in Preclinical Study

Credit: Willfried Wende/Pixabay

 
 
Advertisement
 

RELATED ARTICLES

New Test Can Detect COVID-19 Antibodies Rapidly and Accurately

News

A team of Western University researchers has developed a simple test – faster and more accurate than any approved thus far in Canada – to determine who has developed COVID-19 antibodies.

READ MORE

Myelin-Targeting T Cells Found in MS-Mimicking Monkey Disease

News

Scientists have uncovered new clues to the immune infiltration of the brain seen in a central nervous system disease in monkeys that mimics multiple sclerosis.

READ MORE

Tracking AAV Gene Transfer Vector Biodistribution

News

The biodistribution of adeno-associated virus (AAV) gene transfer vectors can be measured in nonhuman primates using a new method. The method quantifies whole-body and organ-specific AAV capsids from 1 to 72 hours after administration.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE